跳至主要内容
临床试验/NCT03943186
NCT03943186已完成不适用

Non-interventional Study to Investigate the Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Bitop AG1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2018年12月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bitop AG
入组人数
102
试验地点
1
主要终点
Change in Pharyngitis symptom score evaluated by the physician

研究概览

简要总结

The goal of this non-interventional study is to investigate the safety, efficacy and tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.

详细描述

The current non-interventional study aims to investigate the efficacy and tolerability of Ectoin Lozenges Honey Lemon in patients suffering from acute viral pharyngitis. Participants receive treatments as part of routine medical care, and participants can choose one of two treatment options: a) Ectoin Lozenges Honey Lemon or b) lozenges containing hyaluronic acid and icelandic moss.

Efficacy will be studied by documentation of the following symptoms:

  • pain on swallowing
  • hoarseness
  • urge to cough
  • dry mouth and throat
  • redness of oropharynx and larynx
  • sore throat
  • impairment of free breathing
  • general feeling of illness

In parallel, participating patients will document their symptoms over the entire study duration in patient diaries.

The observation takes place over a period of seven days.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with acute viral pharyngitis

排除标准

  • patients with known intolerance to one of the substances used
  • Pregnancy
  • Surgical Procedures in the mouth and throat region prior to the study
  • Bacterial Pharyngitis
  • symptoms in the throat since more than 5 days
  • Contraindications according to the instructions for use

结局指标

主要结局

Change in Pharyngitis symptom score evaluated by the physician

时间窗: day 1 and day 7

The intensity of the symptoms will be graded on a continuous numeric scale, i.e. absent-0, severe-10. The following signs and symptoms will be documented: * pain on swallowing * hoarseness * urge to cough * dry mouth and throat * reddening of oropharynx * reddening of larynx * sore throat * impairment of free breathing * patient's general condition

次要结局

  • Evaluation how efficient the treatment is judged by physician(day 7)
  • Change of Saliva production evaluated by the physician(day 7)
  • Evaluation how treatment is tolerated (judged by patients)(7 days)
  • Evaluation of compliance evaluated by physician(day 7)
  • Change in Pharyngitis Symptoms evaluated in patient's diaries(7 days)
  • Evaluation how treatment is tolerated (judged by physician)(day 7)
  • Incidence of adverse events/serious adverse events(7 days)
  • Evaluation how efficient the treatment is judged by patient(7 days)

研究者

发起方
Bitop AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验